TEZSPIRE

Formula & Concentration

TEZSPIRE – tezepelumab-ekko 210 MG/1.91 ML (110 MG/ML) subcutaneous syringe

Manufacturer

Amgen USA Inc.

Indications

TEZSPIRE – tezepelumab-ekko 210 MG/1.91 ML (110 MG/ML) subcutaneous syringe

Product Options

Package Size

NDC #

Presentation

210 MG

55513-0112-01

PREFILLED SYRINGE


210 MG

55513-0123-01

PEN INJCTR

Shelf Life and Storage

Fridge (2-8°C)